224 related articles for article (PubMed ID: 32504181)
21. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.
Fernandez-Cuesta L; Sexton-Oates A; Bayat L; Foll M; Lau SCM; Leal T
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390794. PubMed ID: 37229617
[TBL] [Abstract][Full Text] [Related]
22. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
23. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
24. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
[TBL] [Abstract][Full Text] [Related]
26. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
Xu J; Zhang T; Wang T; You L; Zhao Y
Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers.
Kaemmerer D; Specht E; Sänger J; Wirtz RM; Sayeg M; Schulz S; Lupp A
J Clin Endocrinol Metab; 2015 Mar; 100(3):831-40. PubMed ID: 25494861
[TBL] [Abstract][Full Text] [Related]
28. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
[TBL] [Abstract][Full Text] [Related]
29. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
30. Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.
Dam G; Grønbæk H; Sundlöv A; Botling J; Sundin A; Petersen RH; Welin S; Evensen ET; Sorbye H; Tabaksblat E; Arveschoug AK; Mortensen J; Kjaer A; Knigge U; Tiensuu Janson E; Langer SW
Acta Oncol; 2023 May; 62(5):431-437. PubMed ID: 37194281
[TBL] [Abstract][Full Text] [Related]
31. DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Yao J; Bergsland E; Aggarwal R; Aparicio A; Beltran H; Crabtree JS; Hann CL; Ibrahim T; Byers LA; Sasano H; Umejiego J; Pavel M
Oncologist; 2022 Nov; 27(11):940-951. PubMed ID: 35983951
[TBL] [Abstract][Full Text] [Related]
32. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.
Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A
Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300
[TBL] [Abstract][Full Text] [Related]
33. Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors.
Galván JA; González MV; Crespo G; Folgueras MV; Astudillo A
Lung Cancer; 2010 Sep; 69(3):289-95. PubMed ID: 20089328
[TBL] [Abstract][Full Text] [Related]
34. [Advances of pathological diagnosis and molecular pathology of lung neuroendocrine neoplasms].
Wu JH; Zhu YL; Wang HY; Liu YH; Lin DM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):109-115. PubMed ID: 38281776
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
Zeng YR; Han ZD; Wang C; Cai C; Huang YQ; Luo HW; Liu ZZ; Zhuo YJ; Dai QS; Zhao HB; Liang YX; Zhong WD
BMC Urol; 2015 Aug; 15():90. PubMed ID: 26320076
[TBL] [Abstract][Full Text] [Related]
36. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.
Kreuz S; Holmes KB; Tooze RM; Lefevre PF
Mol Cancer; 2015 Dec; 14():205. PubMed ID: 26643319
[TBL] [Abstract][Full Text] [Related]
37. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.
Zhao D; Han W; Liu X; Cui D; Chen Y
Thorac Cancer; 2017 Jul; 8(4):304-311. PubMed ID: 28514100
[TBL] [Abstract][Full Text] [Related]
39. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma.
Zeng L; Fan X; Wang X; Deng H; Zhang X; Zhang K; He S; Li N; Han Q; Liu Z
BMC Med Genomics; 2020 Oct; 13(1):158. PubMed ID: 33109182
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
